Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - metronidazole, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; citric acid; sodium chloride; dibasic sodium phosphate - metronidazole juno is indicated for:treatment of severe anaerobic infection when oral medication is not possible or is contraindicated, when immediate anti-anaerobic therapy is required. metronidazole may be used prophylactically to prevent infection of the surgical site which may have been contaminated or potentially contaminated with anaerobic organisms. procedures in which this may be assumed to have happened include appendectomy, colonic surgery, vaginal hysterectomy, abdominal surgery in the presence of anaerobes in the peritoneal cavity and surgery performed in the presence of anaerobic septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - metronidazole -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - metronidazole -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - metronidazole - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - metronidazole - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - metronidazole - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - metronidazole - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - metronidazole - oral tablet - 500mg

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - metronidazole, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate dodecahydrate; water for injections; citric acid monohydrate - metronidazole baxter intravenous infusion is indicated for treatment of anaerobic infections in patients for whom oral administration is not possible. where immediate anti-anaerobic chemotherapy is required. where prophylactic cover is required at lower abdominal surgical sites presumed contaminated or potentially contaminated by anaerobic micro-organisms. procedures of this type include appendectomy, colonic surgery, vaginal hysterectomy, abdominal surgery in the presence of anaerobes in the peritoneal cavity and surgery performed in the presence of anaerobic septicaemia. note: metronidazole is inactive against aerobic or facultative anaerobic bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - metronidazole, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; dibasic sodium phosphate; water for injections - metronidazole claris intravenous infusion is indicated for treatment of anaerobic infections in patients for whom oral administration is not possible. where immediate anti-anaerobic chemotherapy is required. where prophylactic cover is required at lower abdominal surgical sites presumed contaminated or potentially contaminated by anaerobic micro-organisms. procedures of this type include appendectomy, colonic surgery, vaginal hysterectomy, abdominal surgery in the presence of anaerobes in the peritoneal cavity and surgery performed in the presence of anaerobic septicaemia. note: metronidazole is inactive against aerobic or facultative anaerobic bacteria.